Filed with ASX · · 12 pages · English
This filing is a Change of Director's Interest Notice from Radiopharm Theranostics Limited, detailing changes in the interests of four directors in the company's securities. The notice includes information about the acquisition of fully paid ordinary shares and listed options by the directors. It confirms that no interests were traded during a closed period requiring prior written clearance. The document complies with ASX listing rule requirements for reporting director interests.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1 Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents...
Radiopharm Theranostics Limited on 6ix
